CLINICAL_TRIALS
withdrawal
· 2013-05-21
Clinical Trial Update: A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema [Phase 2]
Summary
A Phase 2 study evaluating denufosol tetrasodium intravitreal injection for cystoid macular edema following cataract surgery has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Macular Edema, Cystoid | Phase 2 | Status: WITHDRAWN